New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
08:05 EDTBSXBoston Scientific's Synergy stent system reports strong performance data
Boston Scientific reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the Synergy Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System to the PROMUS Element Stent System. The primary clinical and angiographic endpoints of this non-inferiority study have already been published.
News For BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
10:00 EDTBSXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:12 EDTBSXBoston Scientific upgraded to Buy on valuation at Goldman
Subscribe for More Information
August 24, 2015
16:32 EDTBSXBoston Scientific announces CE Mark for MRI labeling for ICD, CRT-D systems
Boston Scientific has received CE Mark on magnetic resonance imaging conditional labeling for the current family of EL and MINI implantable cardioverter defibrillator and the X4 cardiac resynchronization therapy defibrillator systems. This revised labeling ensures that future patients and those already implanted with these systems are able to undergo MRI scans if indicated.
August 19, 2015
16:48 EDTBSXBoston Scientific announces FDA approval of Innova Self-Expanding Stent System
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use